左卡尼汀注射液治疗慢性心力衰竭患者的疗效观察被引量：3

在线阅读下载PDF

导出

摘要目的观察左卡尼汀注射液对于慢性心力衰竭患者的治疗效果。方法将100例慢性心力衰竭患者随机分为两组,试验组(A组)和对照组(B组)。B组给以心衰患者的标准化治疗方案,A组在B组基础上给以左卡尼汀注射液,治疗两周后,结合B型尿钠肽(BNP)、6分钟步行试验、左室射血分数(LVEF)观察两组治疗效果。结果试验组血浆BNP低于对照组(P<0.05);试验组6分钟步行试验距离长于对照组(P<0.05);试验组左室射血分数高于对照组(P<0.05)。结论在标准化治疗慢性心衰患者的基础上联合运用左卡尼汀注射液能显著改善患者的治疗效果。

作者王勇王贤恩

机构地区湖北省恩施土家族苗族自治州中心医院

出处《中西医结合心脑血管病杂志》 2015年第17期1968-1969,共2页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease

关键词慢性心力衰竭 B型尿钠肽 6分钟步行试验左卡尼汀注射液

分类号 R541.6 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献7

1Ingwall JS. Energy metabolism in heart failure and remodelling [J]. Cardiovasc Res, 2009,81 (3) : 412 - 419.
2van Bilsen M, Smeets PJ, Gilde A J, et al. Metabolic remodelling of the failing heart, the cardiac burn - out syndrome[J]. Cardiovasc Res, 2004,61 (2) : 218 - 226.
3Ferrari R, Pepi P, Ferrari F, et al. Metabolic derangement in ischemicheart disease and its therapeutic control[J]. Am J Cardiol, 1998,82(5A) :2K - 13K.
4殷仁富,王咏梅,张家友,赵君,陈金明,左明良,吴宗贵,仇韶华,梅长林,顾书华.慢性充血性心力衰竭患者血浆游离肉碱浓度的测定及临床意义[J].中国综合临床,2002,18(5):410-411. 被引量：24
5唐瑞康.左卡尼汀治疗心血管疾病的临床应用[J].当代医学,2012,18(18):22-24. 被引量：13
6Rizxos I. Three - year survival of patients with heart failure caused by dilated cardiomyopathy and L - carnitine administration [J]. Am Heart J, 2000,139(2 pt 3) :s120- 123.
7Losterh,Miehe K, Punzel M, et al. Prolonged oral L - carnitine substitution increases bicycle ergometer performance in patients with severe,ischemically induced cardiac insufficiency[J]. Cardiovasc Drugs Ther, 1999,13(6) :537 - 546.

二级参考文献34

1何勇,郑强荪,张录兴,金葵花.左旋卡尼汀治疗慢性充血性心力衰竭的疗效观察[J].心脏杂志,2005,17(1):49-51. 被引量：24
2李玉香.左卡尼丁治疗心绞痛72例临床疗效分析[J].中国心血管杂志,2005,10(5):377-378. 被引量：3
3王咏梅殷仁富等.中国产左旋卡尼汀治疗心绞痛的临床研究[J].国际心血管杂志,2001,3(1):30-32.
4曹玉,刘成娟,孙永旭,薛玉增,王春波.左卡尼汀对离体家兔心脏缺血再灌注损伤的保护作用[J].山东医药,2007,47(28):30-31. 被引量：3
5Mason E,Stofan DA,Szweda Ll.lnhibition of very long chain acyl- CoA dehydrogenase during cardiac ischemia[J].Arch Biochem Biophys,2005,437 (2): 138-143.
6Carvani M,Reda E,Arrigoni- Martelli E.Ragulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions[J]. Basic Res Cardiol,2000,95(1 ): 75- 83.
7Nemoto S,Yasuhara K,Nakamura K,et aI.Plasm a carnitine concentrations in patients undergoing open heart surgery[J].Ann Thorac Cardiovasc Surg, 2004, 10(1), 19-22.
8Paulyd F,Pepine CJ.The role of carnitine dysfunction[J].Am J Kidney Dis,2005,41(Suppl 4):55- 43.
9Gorur S,Bagdatog]u OT,Polat O.Protective effect on renal ischaemia--reperfusion injury in the rat[J] n myocardia of L-carnitine Cell Biochem Funct,2005,23(5):151-155.
10Palermo V,Falcone C,Calvani M,et aI.AcetyI-L-carnitine protects yeast ceils from apoptosis and aging and inhibitsmitochondrial fission[J].Aging Cell, 2010,9(4):570-579.